Randox in the Racing World - Sensitive Screening Solutions
News Mar 23, 2009
Randox supply a comprehensive range of diagnostic solutions for the detection of prohibited substances in international racing.
Randox have developed a new novel screening technology known as Biochip Array Technology. This latest revolution from Randox can be used for testing samples from Equine and Canine racing samples. Randox Biochip Array Technology is a screening system which enables simultaneous testing of multiple analytes using one single sample. It is a technology based on ELISA principles - but rather than binding antibodies to a microtitre plate the analytes are bound to a 9mm x 9mm Biochip on different X Y co-ordinates. Randox offer a wide portfolio of drugs of abuse, growth promoters, synthetic steroids and their metabolites.
Randox also have a comprehensive range of ELISA kits which includes Beta-agonists, Boldenone, Corticosteroids, 19-Nortestosterone/Trenbolone, Ractopamine, Stanozolol, Trenbolone, Phenylbutazone and Zeranol, with the release of a Flunixin and Ketamine ELISA coming soon. All kits offer excellent limits of detection, a wide range of sample matrices, small sample volume and outstanding cross reactivity.
To complement our range of screening tests Randox have developed a range of immunoaffinity columns for sample purification prior to sample analysis by screening or confirmatory technology such as GC/MS, LC/MS. Randox immunoaffinity columns are efficient, whilst also being cost-effective and convenient. Available columns have long shelf lives and come with equilibration and storage buffers. Available columns include Clenbuterol/ß-agonists, Corticosteroids, Trenbolone and 19-Nortestosterone, Stilbene, Zeranol and our new multi-analyte Growth Promoter column.
Scientists from the UNC School of Medicine discovered that the anti-inflammatory protein NLRP12 normally helps protect mice against obesity and insulin resistance when they are fed a high-fat diet. The researchers also reported that the NLRP12 gene is underactive in people who are obese, making it a potential therapeutic target for treating obesity and diabetes.READ MORE